Company Profiles

driven by the PitchBook Platform

MSI Methylation Sciences

Description

Developer of small molecule therapy for adjunctive treatment of major depressive disorder. The company's lead product Strada for treatment of major depressive disorder is based upon Ademetionin, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle.

2007

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$30M

Latest Deal Amount

$49.7M

Total Amount Raised

Description

Developer of small molecule therapy for adjunctive treatment of major depressive disorder. The company's lead product Strada for treatment of major depressive disorder is based upon Ademetionin, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle.

Website:

www.methylationsciences.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals
Drug Discovery

Primary Office

108-4475 Wayburne Drive Burnaby, British Columbia V5G 4X4Canada +1 (604) 435-5155
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore MSI Methylation Sciences's full profile, request a free trial.

MSI Methylation Sciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

MSI Methylation Sciences Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BC Advantage FundsVenture CapitalMinority000 0000000 0000
GrowthWorks CapitalVenture CapitalMinority000 0000000 0000
Inventages Venture CapitalVenture CapitalMinority000 0000000 0000
Quark VentureVenture CapitalMinority000 0000000 0000
BC Advantage Funds Venture Capital
GrowthWorks Capital Venture Capital
Inventages Venture Capital Venture Capital
Quark Venture Venture Capital

MSI Methylation Sciences Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Allan FieldsPresident
David MacDonald Ph.DVice President, Product Development & Chief Technology Officer
Nancy HarrisonCo-Founder, President & Chief Business Officer
Beth CameronVice President, Clinical Research
Steven Targum MDChief Medical Officer
Allan Fields President
David MacDonald Ph.D Vice President, Product Development & Chief Technology Officer
Nancy Harrison Co-Founder, President & Chief Business Officer
Beth Cameron Vice President, Clinical Research
Steven Targum MD Chief Medical Officer

MSI Methylation Sciences Board Members (9)

NameRepresentingRoleSinceContact
Info
Allan FieldsMSI Methylation SciencesPresident000 0000
Axel Bouchon Ph.DSelfBoard Member000 0000
Barry GuldMSI Methylation SciencesCo-Founder & Board Member000 0000
Graham JacksonSelfBoard Member000 0000
Gunnar Weikert Ph.DInventages Venture CapitalFounder, Chairman & Chief Executive Officer000 0000
Allan Fields President MSI Methylation Sciences
Axel Bouchon Ph.D Board Member Self
Barry Guld Co-Founder & Board Member MSI Methylation Sciences
Graham Jackson Board Member Self
Gunnar Weikert Ph.D Founder, Chairman & Chief Executive Officer Inventages Venture Capital
Request full access to PitchBook